Alpha-2 Macroglobulin for the Treatment of Neuroma Pain in the Stump of a Below-Knee Amputee Patient

References

• Finnerup NB , HaroutounianS , KamermanPet al. Neuropathic pain: an updated grading system for research and clinical practice. Pain157(8), 1599–1606 (2016).
   PubMed Web of Science ®Google Scholar
• Bies M , AshmoreZ , QuW , HuntC. Injectable biologics for neuropathic pain: a systematic review. Pain Med.23(10), 1733–1749 (2022).
   PubMed Web of Science ®Google Scholar
• Perrot S , PickeringG , Lanteri-MinetM , AttalN. Real-life management pathways for chronic peripheral neuropathic pain at tertiary pain clinics in France. Pain Med.22(4), 875–882 (2021).
   PubMed Web of Science ®Google Scholar
• Diaz M , CaylorJ , StrigoIet al. Toward composite pain biomarkers of neuropathic pain—focus on peripheral neuropathic pain. Frontiers Pain Res.3, 869215 (2022).
   Google Scholar
• Shamoun F , ShamounV , AkhavanA , TuffahaSH. Target receptors of regenerating nerves: neuroma formation and current treatment options. Front Mol Neurosci.15, 859221 (2022).
   PubMed Web of Science ®Google Scholar
• Lu C , SunX , WangC , WangY , PengJ. Mechanisms, and treatment of painful neuromas. Rev. Neurosci.29(5), 557–566 (2018).
   PubMed Web of Science ®Google Scholar
• Jordan S , LovineJ , KuhnT , GelabertH. Neurogenic thoracic outlet syndrome and other forms of cervical branch brachial syndrome treated with plasma concentrate enriched for alpha 2 macroglobulin. Pain Physician23, 229–233 (2020).
   PubMed Web of Science ®Google Scholar
• Brooks B , LeishearK , AronsonRet al. The use of alpha-2 macroglobulin as a novel treatment for patients with chronic pelvic pain. Int. J. Gynaecol. Obstet.152(3), 454–456 (2021).
   PubMed Web of Science ®Google Scholar
• Fregman F , MuratoriL , SimoesA , Giacobini-RobecchiM , RaimondoS. Role of inflammatory cytokines in peripheral nerve injury. Neural Regen. Res.7(29), 2259–2266 (2012).
   PubMed Web of Science ®Google Scholar
• Peng J , YiM , JeongHet al. The voltage-gated proton channel Hv1 promotes microglia-astrocyte communication and neuropathic pain after peripheral nerve injury. Mol. Brain14(1), 1–18 (2021).
   PubMed Web of Science ®Google Scholar
• Vickers ER , KarstenE , FloodJ , LilischkisR. A preliminary report on stem cell therapy for neuropathic pain in humans. J. Pain Res.7, 255–263 (2014).
   PubMed Web of Science ®Google Scholar
• Vaquero J , ZuritaM , RicoMAet al. Intrathecal administration of autologous bone marrow stromal cells improves neuropathic pain in patients with spinal cord injury. Neurosci. Lett.670, 14–18 (2018).
   PubMed Web of Science ®Google Scholar
• Mao H , WeiW , FuXLet al. Efficacy of autologous bone marrow mononuclear cell transplantation therapy in patients with refractory diabetic peripheral neuropathy. Chin. Med. J.132(1), 11–16 (2019).
   PubMed Web of Science ®Google Scholar
• Venturi M , BoccasantaP , LombardiB , BrambillaM , ContessiniAvesani E , VerganiC. Pudendal neuralgia: a new option of treatment? Preliminary results on feasibility and efficacy. Pain Med.16(8), 1475–1481 (2015).
   PubMed Web of Science ®Google Scholar
• Joshi HP , JoHJ , KimYH , AnSB , ParkCK , HanI. Stem Cell Therapy for Modulating Neuroinflammation in Neuropathic Pain. Int. J. Mol. Sci.22(9), 4853 (2021).
   PubMed Web of Science ®Google Scholar
• de Gast H , TorrensmaB , FitzgeraldE , StevensH. The treatment of neuropathic pain: bio (regenerative) pain treatment through lipofilling: a short communication case series. Pain Physician19(3), E495–E498 (2016).
   PubMed Web of Science ®Google Scholar
• Correa Lopez J , CortesH , GarciaCeballos E , QuinteroP. Platelet-rich plasma in treating peripheral neuropathic pain. Preliminary report. Rev. Soc. Esp. Dolor.25(5), 263–270 (2018).
   Google Scholar
• Hassanien M , ElawanyA , KamelEZet al. Perineural platelet-rich plasma for diabetic neuropathic pain, could it make a difference? Pain Med. 21(4), 757–765 (2020).
   PubMed Web of Science ®Google Scholar
• Bohren Y , TimbolschiD , MullerA , BarrotM , YalcinI , SalvatE. Platelet-rich plasma and cytokines in neuropathic pain: a narrative review and a clinical perspective. Eur. J. Pain26(1), 43–60 (2022).
   PubMed Web of Science ®Google Scholar
• Galan V , Inigo-DendariarenaI , GalanI , PradoR , PadillaS , AnituaE. The effectiveness of plasma rich in growth factors (PRGF) in the treatment in nerve compression syndromes of the upper extremity: a retrospective observational clinical study. J. Clin. Med.11(16), 1–10 (2022).
   Web of Science ®Google Scholar
• Aghamohammadi D , SharifiS , ShakouriSK , EslampourY , DolatkhahN. Autologous conditioned serum (orthokine) injection for the treatment of classical trigeminal neuralgia: results of a single center series. J. Med. Case Rep.16(1), 183 (2022).
   PubMedGoogle Scholar
• Goni VG , SinghJhala S , GopinathanNRet al. Efficacy of epidural perineural injection of autologous conditioned serum in unilateral cervical radiculopathy. Spine40(16), E915–E921 (2015).
   PubMed Web of Science ®Google Scholar
• Sodavarapu P , GoniVJ , GhoshA , SandeepP , KumarV , KumarS. Autologous conditioned serum in lumbar and cervical radiculopathy: a systemic review. Biomed. Transl. Res.Springer, Singapore (2022).
   Google Scholar
• de Castro J , WangD , ChangChien GC. Regenerative interventions for neuropathic pain: physiology, ultrasound, and therapies with a focus on alpha-2-macroglobulin. Pain Manag.12(6), 779–793 (2022).
   PubMed Web of Science ®Google Scholar
• de Castro J . Study on alpha-2 macroglobulin: the new weapon for neuropathic pains. Issues and Developments in Medicine and Medical Research2, 17–21 (2022).
   Google Scholar
• de Castro J . Regenerative medicine procedures under ultrasound guidance. Musculoskeletal Ultrasound-Guided Regenerative MedicineElMiedany Y. 287–342Springer, Cham (2022).
   Google Scholar
• Meyer C , HinrichsW , HahnU. Human alpha-2 macroglobulin—another variation on the venus flytrap. Angew. Chem. Int. Ed.51(21), 5045–5047 (2012).
   PubMed Web of Science ®Google Scholar
• Rehman AA , AhsanH , KhanFH. Alpha-2 macroglobulin: a physiological guardian. J. Cell. Physiol.228(8), 1665–1675 (2013).
   PubMed Web of Science ®Google Scholar
• Huang X , WangY , YuCet al. Cryo-EM structures reveal the dynamic transformation of human alpha-2 macroglobulin working as a protease inhibitor. Sci. China Life Sci.65(12), 2491–2504 (2022).
   PubMed Web of Science ®Google Scholar
• Montesano PX , CuellarJM , ScuderiGJ. Intradiscal injection of an autologous alpha-2 macroglobulin (A2M) concentrate alleviates back pain in FAC-positive patients. Ortho. and Rheum.4(2), 1–5 (2017).
   Google Scholar
• Sun C , CaoC , ZhaoTet al. A2M inhibits inflammatory mediators of chondrocytes by blocking IL-1β/NF-κB pathway. J. Orthop. Res.41(1), 241–248 (2022).
   PubMed Web of Science ®Google Scholar
• Arandjelovic S , DragojlovicN , LiX , MyersRR , CampanaWM , GoniasSL. A derivative of plasma protease inhibitor alpha-2 macroglobulin regulates the response to peripheral nerve injury. J. Neurochem.103(2), 694–705 (2007).
   PubMed Web of Science ®Google Scholar